000			02084 a2200601 4500
005			20250516024900.0
264		0	_c20110525
008			201105s 0 0 eng d
022			_a1525-2191
024	7		_a10.1016/j.ajpath.2010.11.058 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Aihua
245	0	0	_aOverexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. _h[electronic resource]
260			_bThe American journal of pathology _cMar 2011
300			_a1340-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation
650	0	4	_aChemokine CXCL5 _xgenetics
650	0	4	_aDisease Progression
650	0	4	_aEndothelial Cells _xenzymology
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeovascularization, Pathologic _xmetabolism
650	0	4	_aNeutralization Tests
650	0	4	_aPancreatic Neoplasms _xblood supply
650	0	4	_aPhosphorylation
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReceptors, Interleukin-8B _xmetabolism
650	0	4	_aSurvival Analysis
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aKing, Jonathan
700	1		_aMoro, Aune
700	1		_aSugi, Mark D
700	1		_aDawson, David W
700	1		_aKaplan, Jeffrey
700	1		_aLi, Gang
700	1		_aLu, Xuyang
700	1		_aStrieter, Robert M
700	1		_aBurdick, Marie
700	1		_aGo, Vay Liang W
700	1		_aReber, Howard A
700	1		_aEibl, Guido
700	1		_aHines, O Joe
773	0		_tThe American journal of pathology _gvol. 178 _gno. 3 _gp. 1340-9
856	4	0	_uhttps://doi.org/10.1016/j.ajpath.2010.11.058 _zAvailable from publisher's website
999			_c20631351 _d20631351